Answer
Zypadhera prolonged-release injection must not be mixed with other medicinal products except those mentioned in section 6.6 of its Summary of Product Characteristics.
Sources for this answer
- ZYPADHERA 210 mg, 300 mg and 405 mg powder and solvent for prolonged release suspension for injectionNeon Healthcare Ltd · emc · SmPC §6.2 Incompatibilities · Version 2Document updated
Sources checked